NOT FOR REPRINT
Page Printed from: benefitspro.com/author/profile/allison/?page=6
Sign In To follow
Federal transparency rules took effect in 2022 but have not worked well.
An Eli Lilly executive warned that some of what labs try to palm off on desperate patients is contaminated.
The obesity and diabetes control drugs accounted for about 5% of U.S. drug spending.
Growing ACA exchange system stability will make the strategy more attractive, executives predict.
ICHRA enrollees may now account for a noticeable fraction of the 24.3 million Americans who had individual or family major medical coverage.
Totalis Benefits will focus on selling life, disability and absence management services.
Walz supports a state public option effort but never backed the House Medicare for All Act bills.
Judge Matthew Kennelly will manage a barrage of suits over whether how payers decide what to pay is legal.
The hospitals that participated sent in more quality data.
Executives predict a continuing shift toward self-funding will keep sales rising.